These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 28550664)
1. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a]. Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664 [No Abstract] [Full Text] [Related]
2. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis. Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941 [TBL] [Abstract][Full Text] [Related]
3. [Apoptosis of NB4 cells induced by Tanshinone II A combined with arsenic trioxide]. Zhang G; Yang YM; Meng WT; Zhou J Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):57-61. PubMed ID: 20369471 [TBL] [Abstract][Full Text] [Related]
4. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines. Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy with 5-amino-4-imidazolecarboxamide riboside and arsenic trioxide in acute myeloid leukemia cells involving AMPK/TSC2/mTOR pathway. Chen L; Han F; Qu H; Yan H; Ren L; Yang S Pharmazie; 2013 Feb; 68(2):117-23. PubMed ID: 23469683 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation. Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096 [TBL] [Abstract][Full Text] [Related]
7. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. Tan M; Zhang Q; Yuan X; Chen Y; Wu Y J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525 [TBL] [Abstract][Full Text] [Related]
8. [Homoharringtonine combined arsenic trioxide induced apoptosis in human multiple myeloma cell line RPMI 8226: an experimental research]. Zhou XJ; Zhou YH; Chen XH; Qian WB Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):834-9. PubMed ID: 23980369 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514 [TBL] [Abstract][Full Text] [Related]
10. Combination of arsenic trioxide and chemotherapy in small cell lung cancer. Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618 [TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo]. Lu J; Jin J Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model]. Lu J; Jin J; Xu WL Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):228-33. PubMed ID: 16624066 [TBL] [Abstract][Full Text] [Related]
14. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation. Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739 [TBL] [Abstract][Full Text] [Related]
15. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Wang R; Liu C; Xia L; Zhao G; Gabrilove J; Waxman S; Jing Y Clin Cancer Res; 2012 Dec; 18(24):6690-701. PubMed ID: 23082001 [TBL] [Abstract][Full Text] [Related]
16. Pure total flavonoids from Citrus paradisi Macfadyen act synergistically with arsenic trioxide in inducing apoptosis of Kasumi-1 leukemia cells in vitro. Wang B; Lin SY; Shen YY; Wu LQ; Chen ZZ; Li J; Chen Z; Qian WB; Jiang JP J Zhejiang Univ Sci B; 2015 Jul; 16(7):580-5. PubMed ID: 26160715 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs. Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Wang R; Xia L; Gabrilove J; Waxman S; Jing Y Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication. Takahashi S; Harigae H; Yokoyama H; Ishikawa I; Abe S; Imaizumi M; Sasaki T; Kaku M Int J Hematol; 2006 Oct; 84(3):256-61. PubMed ID: 17050201 [TBL] [Abstract][Full Text] [Related]